Lacnotuzumab
Lacnotuzumab Uses, Dosage, Side Effects, Food Interaction and all others data.
Lacnotuzumab is under investigation in clinical trial NCT01643850 (MCS110 in Patients With Pigmented Villonodular Synovitis (PVNS)).
Trade Name | Lacnotuzumab |
Generic | Lacnotuzumab |
Lacnotuzumab Other Names | Lacnotuzumab |
Type | |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Lacnotuzumab